Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Mennecier

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Case Reports in Oncology|February 28, 2015
Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR MutationAlexandre Schaller, Michèle Beau-Faller, Bertrand Mennecier, et al.
Journal of Pain and Symptom Management|August 30, 2005
Chemoradiotherapy-induced esophagitis pain relieved by topical morphine: three casesAnne Cecile Gairard-Dory, Carine Schaller, Bertrand Mennecier, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
Successful treatment with ceritinib after crizotinib induced hepatitisMarion Sassier, Bertrand Mennecier, Anthony Gschwend, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Gastrointestinal perforations in patients treated with erlotinib: A report of two cases with fatal outcome and literature reviewFlorence Gass-Jégu, Anthony Gschwend, Anne-Cécile Gairard-Dory, et al.
Lung Cancer (Amsterdam, Netherlands)|February 17, 2005
First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week scheduleElisabeth Quoix, Jean-Luc Breton, Alain Ducoloné, et al.
Lung Cancer (Auckland, N.Z.)|August 18, 2025
Alectinib Efficacy Post-Brigatinib Against Advanced <i>ALK</i>+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)Renaud Descourt, Florian Guisier, Maurice Pérol, et al.
Oncology|June 13, 2008
Epoetin Beta once-weekly therapy in anemic patients with solid tumors and non-myeloid hematological malignancies receiving chemotherapyDominique Spaëth, Bernard Desablens, Philippe Rodon, et al.
Respiration; International Review of Thoracic Diseases|November 17, 2012
Impact of 3D conformal radiotherapy on lung function of patients with lung cancer: a prospective studyIrina Enache, Georges Noel, Mi Young Jeung, et al.
Bulletin Du Cancer|October 10, 2014
[ALK-rearranged non-small cell lung cancer: how to optimize treatment with crizotinib in routine practice?]Clarisse Audigier-Valette, Nicolas Girard, Alexis B Cortot, et al.
Expert Review of Anticancer Therapy|November 22, 2014
ALK-rearranged non-small cell lung cancers: how best to optimize the safety of crizotinib in clinical practice?Nicolas Girard, Clarisse Audigier-Valette, Alexis B Cortot, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Case Reports in Oncology|February 28, 2015
Lung Adenocarcinoma with Pulmonary Miliary Metastases and Complex Somatic Heterozygous EGFR MutationAlexandre Schaller, Michèle Beau-Faller, Bertrand Mennecier, et al.
Journal of Pain and Symptom Management|August 30, 2005
Chemoradiotherapy-induced esophagitis pain relieved by topical morphine: three casesAnne Cecile Gairard-Dory, Carine Schaller, Bertrand Mennecier, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
Successful treatment with ceritinib after crizotinib induced hepatitisMarion Sassier, Bertrand Mennecier, Anthony Gschwend, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Gastrointestinal perforations in patients treated with erlotinib: A report of two cases with fatal outcome and literature reviewFlorence Gass-Jégu, Anthony Gschwend, Anne-Cécile Gairard-Dory, et al.
Lung Cancer (Amsterdam, Netherlands)|February 17, 2005
First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week scheduleElisabeth Quoix, Jean-Luc Breton, Alain Ducoloné, et al.
Lung Cancer (Auckland, N.Z.)|August 18, 2025
Alectinib Efficacy Post-Brigatinib Against Advanced <i>ALK</i>+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study)Renaud Descourt, Florian Guisier, Maurice Pérol, et al.
Oncology|June 13, 2008
Epoetin Beta once-weekly therapy in anemic patients with solid tumors and non-myeloid hematological malignancies receiving chemotherapyDominique Spaëth, Bernard Desablens, Philippe Rodon, et al.
Respiration; International Review of Thoracic Diseases|November 17, 2012
Impact of 3D conformal radiotherapy on lung function of patients with lung cancer: a prospective studyIrina Enache, Georges Noel, Mi Young Jeung, et al.
Bulletin Du Cancer|October 10, 2014
[ALK-rearranged non-small cell lung cancer: how to optimize treatment with crizotinib in routine practice?]Clarisse Audigier-Valette, Nicolas Girard, Alexis B Cortot, et al.
Expert Review of Anticancer Therapy|November 22, 2014
ALK-rearranged non-small cell lung cancers: how best to optimize the safety of crizotinib in clinical practice?Nicolas Girard, Clarisse Audigier-Valette, Alexis B Cortot, et al.
Pageof 5